Shukla Suneet, Abel Biebele, Chufan Eduardo E, Ambudkar Suresh V
From the Laboratory of Cell Biology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892.
From the Laboratory of Cell Biology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892
J Biol Chem. 2017 Apr 28;292(17):7066-7076. doi: 10.1074/jbc.M116.771634. Epub 2017 Mar 10.
P-glycoprotein (P-gp) is a multidrug transporter that uses energy from ATP hydrolysis to export many structurally dissimilar hydrophobic and amphipathic compounds, including anticancer drugs from cells. Several structural studies on purified P-gp have been reported, but only limited and sometimes conflicting information is available on ligand interactions with the isolated transporter in a dodecyl-maltoside detergent environment. In this report we compared the biochemical properties of P-gp in native membranes, detergent micelles, and when reconstituted in artificial membranes. We found that the modulators zosuquidar, tariquidar, and elacridar stimulated the ATPase activity of purified human or mouse P-gp in a detergent micelle environment. In contrast, these drugs inhibited ATPase activity in native membranes or in proteoliposomes, with IC values in the 10-40 nm range. Similarly, a 30-150-fold decrease in the apparent affinity for verapamil and cyclic peptide inhibitor QZ59-SSS was observed in detergent micelles compared with native or artificial membranes. Together, these findings demonstrate that the high-affinity site is inaccessible because of either a conformational change or binding of detergent at the binding site in a detergent micelle environment. The ligands bind to a low-affinity site, resulting in altered modulation of P-gp ATPase activity. We, therefore, recommend studying structural and functional aspects of ligand interactions with purified P-gp and other ATP-binding cassette transporters that transport amphipathic or hydrophobic substrates in a detergent-free native or artificial membrane environment.
P-糖蛋白(P-gp)是一种多药转运蛋白,它利用ATP水解产生的能量将许多结构不同的疏水性和两亲性化合物(包括抗癌药物)排出细胞。已有多项关于纯化的P-gp的结构研究报道,但在十二烷基麦芽糖苷去污剂环境中,关于配体与分离的转运蛋白相互作用的信息有限,且有时相互矛盾。在本报告中,我们比较了P-gp在天然膜、去污剂胶束以及重构于人工膜中的生化特性。我们发现,调节剂唑磺达、 tariquidar和艾拉司群在去污剂胶束环境中刺激纯化的人或小鼠P-gp的ATP酶活性。相比之下,这些药物在天然膜或脂质体中抑制ATP酶活性,IC值在10-40纳米范围内。同样,与天然或人工膜相比,在去污剂胶束中观察到维拉帕米和环肽抑制剂QZ59-SSS的表观亲和力降低了30-150倍。总之,这些发现表明,由于去污剂胶束环境中结合位点的构象变化或去污剂的结合,高亲和力位点无法接近。配体与低亲和力位点结合,导致P-gp ATP酶活性的调节改变。因此,我们建议在无去污剂的天然或人工膜环境中研究配体与纯化的P-gp和其他转运两亲性或疏水性底物的ATP结合盒转运蛋白相互作用的结构和功能方面。